Literature DB >> 32800703

Cell Cycle Regulation Meets Tumor Immunosuppression.

Jinyang Li1, Ben Z Stanger2.   

Abstract

Reciprocal interactions between tumor cells and immune cells shape the tumor microenvironment. Recent studies indicate that enhanced cell cycle activity in cancer cells suppresses antitumor immunity. Herein we discuss potential mechanisms by which cell cycle programs intrinsic to tumor cells are coupled to immune behavior, with consequences for immunotherapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell cycle; immune evasion; immunotherapy; tumor immunology

Mesh：

Year:  2020        PMID： 32800703     DOI： 10.1016/j.it.2020.07.010

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  18 in total

Review 1.  Ganoderma immunomodulatory proteins: mushrooming functional FIPs.

Authors:  Jingwei Lin; Huan Chen; Yudong Bai; Shoukun Li; Gengyuan Liang; Tianning Fan; Ningyuan Gao; Xiupeng Wu; Hui Li; Gang Chen; Yingxu Gao; Jungang Fan
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-29       Impact factor: 4.813

2.  A Cell Component-Related Prognostic Signature for Head and Neck Squamous Cell Carcinoma Based on the Tumor Microenvironment.

Authors:  Siyu Li; Yajun Gu; Junguo Wang; Dengbin Ma; Xiaoyun Qian; Xia Gao
Journal:  Int J Genomics       Date:  2022-06-25       Impact factor: 2.758

3.  Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy.

Authors:  Enyu Lin; Ping Zhu; Chujin Ye; ManLi Huang; Xuechao Liu; Kaiwen Tian; Yanlin Tang; Jiayi Zeng; Shouyu Cheng; Jiumin Liu; Yanjun Liu; Yuming Yu
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

4.  Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy.

Authors:  Fei Kuang; Juan Du; Mengjia Zhou; Fangyi Peng; Yu Gan; Cheng Fang; Xiaoli Yang; Bo Li; Song Su
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 5.  Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma.

Authors:  Paul J Bröckelmann; Mathilde R W de Jong; Ron D Jachimowicz
Journal:  Cells       Date:  2020-10-14       Impact factor: 6.600

6.  PDZ Binding Kinase/T-LAK Cell-Derived Protein Kinase Plays an Oncogenic Role and Promotes Immune Escape in Human Tumors.

Authors:  Tingting Feng; Yan Zhang; Sunbin Ling; Chenyang Xu; Yingqi Lyu; Tingting Lu; Xinyuan Liu; Lisha Ying; Yafeng Wan; Haijun Zhong; Dan Su
Journal:  J Oncol       Date:  2021-09-23       Impact factor: 4.375

7.  Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach.

Authors:  Simran Venkatraman; Brinda Balasubramanian; Pisut Pongchaikul; Rutaiwan Tohtong; Somchai Chutipongtanate
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

8.  Discovery of tumor immune infiltration-related snoRNAs for predicting tumor immune microenvironment status and prognosis in lung adenocarcinoma.

Authors:  Rongjun Wan; Lu Bai; Changjing Cai; Wang Ya; Juan Jiang; Chengping Hu; Qiong Chen; Bingrong Zhao; Yuanyuan Li
Journal:  Comput Struct Biotechnol J       Date:  2021-11-25       Impact factor: 7.271

Review 9.  Cell cycle on the crossroad of tumorigenesis and cancer therapy.

Authors:  Jing Liu; Yunhua Peng; Wenyi Wei
Journal:  Trends Cell Biol       Date:  2021-07-22       Impact factor: 20.808

10.  Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.

Authors:  Xiaomao Yin; Zaoyu Wang; Jianfeng Wang; Yunze Xu; Wen Kong; Jin Zhang
Journal:  Oncoimmunology       Date:  2021-06-30       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.